Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy.

Hofmann M, Stoss O, Gaiser T, Kneitz H, Heinmöller P, Gutjahr T, Kaufmann M, Henkel T, Rüschoff J.

J Clin Pathol. 2008 Jan;61(1):89-94. Epub 2007 Apr 5.

PMID:
17412870
2.

HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin.

Heinmöller P, Gross C, Beyser K, Schmidtgen C, Maass G, Pedrocchi M, Rüschoff J.

Clin Cancer Res. 2003 Nov 1;9(14):5238-43.

3.

High plating density improves Big Blue system efficiency without loss of sensitivity.

Heinmöller PW, Hill KA, Sommer SS.

Mutat Res. 2000 Sep 20;453(1):97-103.

PMID:
11006417
4.

Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.

Heinmöller E, Dietmaier W, Zirngibl H, Heinmöller P, Scaringe W, Jauch KW, Hofstädter F, Rüschoff J.

Am J Pathol. 2000 Jul;157(1):83-92.

5.

Spontaneous mutation frequency and pattern in Big Blue mice fed a vitamin E-supplemented diet.

Moore SR, Hill KA, Heinmoller PW, Halangoda A, Kunishige M, Buettner VL, Graham KS, Sommer SS.

Environ Mol Mutagen. 1999;34(2-3):195-200.

PMID:
10529744
6.

Selective HPLC Analysis of n-Alkyl Hydroperoxides up to C(18)H(38)O(2).

Heinmöller P, Kurth HH, Rabong R, Turner WV, Kettrup A, Gäb S.

Anal Chem. 1998 Apr 1;70(7):1437-9. doi: 10.1021/ac970867o.

PMID:
21644738

Supplemental Content

Loading ...
Support Center